What is Deciduous Therapeutics worth?
$45.0Mlast known valuation
Deciduous Therapeutics last raised $5.8M in its Early Stage VC (Jun 2019).
Free account
See the evidence behind this price
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 20 names
- ·Watchlist + deal alerts for Deciduous Therapeutics
Create free account
No card required
Funding history
1 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Jun 2019 | Early Stage VC | $5.8M | ▮ | ▮ |
How Deciduous Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Deciduous Therapeutics, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is Deciduous Therapeutics worth?
- Deciduous Therapeutics's last known valuation is $45.0M.
- How much has Deciduous Therapeutics raised?
- Deciduous Therapeutics has raised $26.5M in total funding across 1 recorded rounds.
- When did Deciduous Therapeutics last raise?
- Deciduous Therapeutics last raised in Jun 2019 (Early Stage VC), raising $5.8M.